Trial Profile
Phase 2a Study of Boceprevir for the Treatment of Genotype 6 Hepatitis C
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Oct 2013 New trial record